Metastatic castration-resistant prostate cancer and the challenge of a patient with chronic kidney disease in hemodialysis
Autops. Case Rep
;
8(2): e2018011, Apr.-May 2018. ilus graf
Artículo
en Inglés
| LILACS
| ID: biblio-905587
ABSTRACT
At a time when the population shows increasing longevity, entities such as cancer and chronic kidney disease (CKD) are more frequently connected. In the United States, approximately 6% of the patients on hemodialysis have cancer. The challenge to manage oncologic patients with CKD in a hemodialytic program represents a great shortage of available information on the choice of the best drug, timing, dosage adjustments, dialysis method, and treatment safety. We present the case of a patient with prostate cancer and terminal CKD in hemodialysis, and the treatment sequence after the development of resistance to hormonal blockade therapy, which included docetaxel, enzalutamide, and radium-223.
Texto completo:
Disponible
Índice:
LILACS (Américas)
Asunto principal:
Neoplasias de la Próstata
/
Adenocarcinoma
/
Diálisis
/
Insuficiencia Renal Crónica
/
Antineoplásicos
Límite:
Humanos
/
Masculino
Idioma:
Inglés
Revista:
Autops. Case Rep
Asunto de la revista:
Anatomia
/
Patologia Cl¡nica
/
Patologia Legal
Año:
2018
Tipo del documento:
Artículo
País de afiliación:
Portugal
Institución/País de afiliación:
University of Porto/PT
Similares
MEDLINE
...
LILACS
LIS